Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Infectious Disease Therapeutics Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The infectious disease therapeutics market size has demonstrated robust growth in recent years. It is projected to expand from $141.08 billion in 2024 to $150.6 billion in 2025, showing a compound annual growth rate (CAGR) of 6.7%. The historical increase can be attributed to several factors including the rising prevalence of infectious diseases, the increasing incidence of viral diseases, greater awareness about diagnosis, a rising demand for efficient and quick diagnostic testing, a growing demand for cost-effective generic drugs, the growing prevalence of infectious diseases, and the growing importance of antimicrobial stewardship.
The infectious disease therapeutics market size is anticipated to undergo significant expansion in the coming years. It is projected to reach “$191.97 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period is primarily driven by factors such as increasing investments, the broadening of clinical trial studies, a rise in the number of clinical trials, a greater emphasis on infectious disease prevention, heightened awareness regarding early diagnosis, and increasing overall awareness and funding. Major developments expected in the forecast period include strategic partnerships, product approvals, continued investments, and advancements in research and development within therapeutics.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
What Are The Key Drivers Of Growth In The Infectious Disease Therapeutics Market?
The increasing occurrence of infectious diseases is projected to drive the expansion of the infectious disease therapeutics market in the coming period. Such diseases represent ailments brought on by disease-causing microorganisms like bacteria, viruses, fungi, parasites, or prions. The escalation in infectious diseases stems from various principal factors including climate shifts and environmental disturbances, resistance to antimicrobials, compromised immune systems, greater contact with animals, and ecological imbalances. Infectious disease therapeutics are crucial for addressing infections, diminishing sickness and fatalities, and managing the dissemination of transmissible conditions within and across populations. For example, in November 2023, as per the Centers for Disease Control and Prevention, a US-based government agency, the United States registered 8,331 tuberculosis (TB) cases in 2022, displaying an incidence rate of 2.5 per 100,000 people. This represents a 5.9% increase in case numbers and a 5.5% rise in the incidence rate compared to 2021. Consequently, the growing prevalence of infectious diseases acts as a driver for the infectious disease therapeutics market.
How Is The Infectious Disease Therapeutics Market Classified Into Different Segments?
The infectious disease therapeuticsmarket covered in this report is segmented –
1) By Type: Drugs; Vaccines
2) By Disease: Tuberculosis; HIV/AIDS; Influenza; Hepatitis; Other Diseases
3) By End-User: Hospitals And Clinics; Retail Pharmacies; Research Organizations; Other End Users
Subsegments:
1) By Drugs – Antibiotics; Antivirals; Antifungals; Antiparasitics; Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines – Inactivated Vaccines; Live Attenuated Vaccines; Subunit Vaccines; Mrna Vaccines; Dna Vaccines; Toxoid Vaccines
How Are Emerging Market Trends Shaping The Infectious Disease Therapeutics Industry Landscape?
Major companies operating in the infectious disease therapeutics market are channeling investments into infectious disease drugs to develop superior treatments, effectively combat antimicrobial resistance, broaden their product portfolios, and address novel infectious threats. These financial undertakings are intended to enhance patient outcomes, meet existing unmet medical needs, and support global public health efforts aimed at controlling and managing infectious diseases. For instance, in June 2022, GSK, a UK-based healthcare company, invested £1 billion ($1.09 billion) to proactively tackle infectious diseases prevalent in lower-income countries. This specific initiative seeks to bolster research and development endeavors focused on combating diseases that disproportionately affect these regions. The notable disparity in health research funding and resources between high-income nations and low- and middle-income countries highlights the critical urgency for such forward-thinking investments to equitably improve population health.
Which Leading Players Are Enhancing Their Infectious Disease Therapeutics Market Presence Worldwide?
Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Infectious Disease Therapeutics Industry Expansion?
North America was the largest region in the infectious disease therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Infectious Disease Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Therapeutics Market 2025, By The Business Research Company
Veterinary Infectious Disease Diagnostics Global Market Report 2025
Veterinary Anti Infectives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report
Infection Prevention Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model